BioInnovation Institute

Nordic Virtual Pastures is a Copenhagen-based company developing technologies to accelerate the cultured meat revolution. It proposes a platform around Virtual Media for propagating meat cells, paired with low-cost, sustainable cell growth liquids that support scalable, industrial production. The company aims to address ethical and environmental concerns associated with conventional meat by enabling fully scaled production with reduced cost and resource use. It emphasizes purification of biomass waste streams from existing processes to extract nutrients in a cost-effective, sustainable manner, supporting meat industries to achieve larger-scale facilities. Founded in 2021, the firm positions itself as enabling a more sustainable meat supply through novel cell-culture inputs and waste-stream valorization, targeting the transition away from traditional livestock farming toward cultured meat production.

Founded in 2022, Ousia Pharma is a Danish biotech company dedicated to developing pharmacotherapies for individuals with obesity and metabolic disorders. The company's innovative approach involves using peptides to deliver modulators of synaptic plasticity to the brain, achieving potent and sustained weight loss while maintaining safety.

Myco4Food is a biotechnology research company founded in 2022 and headquartered in Copenhagen, Denmark. It focuses on developing protein alternatives and novel food products by upcycling solid waste from the food and agricultural sectors. Utilizing a scalable bioreactor system that employs solid-state fermentation technology, Myco4Food transforms organic waste into protein-rich food ingredients, enzymes, and other valuable materials. The company's innovative approach aims to offer sustainable solutions that reduce carbon emissions and land use within the food industry, while also producing competitively priced alternatives. Through its efforts, Myco4Food contributes to a more sustainable food system by addressing waste and enhancing resource efficiency.

Founded in 2021 and headquartered in Copenhagen, EvodiaBio is a bio-industrial company specializing in the creation of natural, sustainable scents for the food and beverage industries.

Probmet is a precision oncology therapeutics company founded in 2022 and based in Copenhagen, Denmark. The company focuses on developing targeted treatments specifically for breast cancer and patients with brain metastases. By leveraging advanced therapeutic platforms, Probmet aims to provide effective solutions for these life-threatening conditions, ultimately helping patients to manage their illnesses and improve their quality of life.

Founded in 2022, Ousia Pharma is a Danish biotech company dedicated to developing pharmacotherapies for individuals with obesity and metabolic disorders. The company's innovative approach involves using peptides to deliver modulators of synaptic plasticity to the brain, achieving potent and sustained weight loss while maintaining safety.

Nordic Virtual Pastures is a Copenhagen-based company developing technologies to accelerate the cultured meat revolution. It proposes a platform around Virtual Media for propagating meat cells, paired with low-cost, sustainable cell growth liquids that support scalable, industrial production. The company aims to address ethical and environmental concerns associated with conventional meat by enabling fully scaled production with reduced cost and resource use. It emphasizes purification of biomass waste streams from existing processes to extract nutrients in a cost-effective, sustainable manner, supporting meat industries to achieve larger-scale facilities. Founded in 2021, the firm positions itself as enabling a more sustainable meat supply through novel cell-culture inputs and waste-stream valorization, targeting the transition away from traditional livestock farming toward cultured meat production.

FLASH Diagnostics is a Copenhagen-based company founded in 2021 that specializes in 3D histopathology for cancer diagnosis. The company focuses on employing three-dimensional screening techniques to analyze complete cancer resections, allowing for the precise quantification of cancer spread and accurate patient staging. By enhancing traditional microscopy methods, FLASH Diagnostics aims to improve the accuracy of cancer diagnoses, ultimately benefiting medical practitioners and their patients in the clinical setting.

Stimuliver is a biotechnology company developing a 3D liver implant intended for treating critically failing liver function. Founded in 2021 and based in Copenhagen, Denmark.

Embark Biotech is an early-stage biotechnology company based in Copenhagen, Denmark, founded in 2017. The company focuses on identifying novel cell surface receptors that play a critical role in regulating calorie-burning in fat tissue, as well as the uptake of glucose and lipids. By developing receptors that stimulate energy expenditure without activating the sympathetic nervous system, Embark Biotech aims to address unmet clinical needs in the field of metabolic diseases.

Founded in 2018, Sundew is a biotechnology company based in Copenhagen. It specializes in providing biological services for treating aquatic pests and diseases using precision fermentation.

Ciana Therapeutics is a clinical development-stage company based in Copenhagen, Denmark, established in 2019. The company specializes in creating innovative therapies aimed at treating diabetic retinopathy, a complication of diabetes that can lead to vision loss and blindness. Ciana's therapeutic approach involves a novel treatment that stabilizes and protects retinal capillaries, thereby preventing structural breakdown, vascular leakage, and retinal edema. Through its research and development efforts, Ciana Therapeutics aims to provide effective solutions for patients suffering from the visual impairments associated with diabetes.

BOOST Pharma is a biotechnology research company based in Copenhagen, Denmark, founded in 2019. The company specializes in developing a stem cell therapy aimed at treating osteogenesis imperfecta, a genetic disorder characterized by fragile bones. BOOST Pharma's innovative approach utilizes novel mesenchymal stem cells known for their strong bone-forming capabilities. Once injected into patients, these stem cells migrate to the bone, where they engraft and initiate the process of bone formation. This therapeutic strategy enables clinicians to address the disease at its earliest stages, potentially enhancing long-term outcomes for patients.

Cirqle Biomedical is a Copenhagen-based biotech company focused on advancing women's health through innovative contraceptive solutions. The company is developing a non-hormonal contraceptive technology that utilizes mucus engineering principles to create a temporary barrier in cervical mucus, preventing sperm from entering the uterus. This approach aims to provide women with greater control over their reproductive choices without the use of traditional hormonal methods. By prioritizing women's freedom and quality of life, Cirqle Biomedical seeks to transform contraceptive options and enhance reproductive health.

Proxi Biotech is a biotechnology company headquartered in Copenhagen, Denmark, founded in 2017. It specializes in developing a bacteria-resistant vaccine aimed at treating multi-drug-resistant bacterial infections. Utilizing its BACTOVAC platform technology, the company focuses on detoxifying bacterial toxins and effectively eliminating multi-drug-resistant bacteria. Proxi Biotech's innovations address significant infectious disease challenges, contributing to improved public health outcomes and enabling patients to maintain healthier lives.

Kariya Pharmaceuticals is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company focuses on developing innovative drugs aimed at treating neurodegenerative diseases, specifically Parkinson's and Alzheimer's. Its drug candidates utilize dual incretin receptors, which are designed to slow the progression of these conditions, offering potential therapeutic benefits to patients affected by these debilitating diseases.

RetiPharma is a biotechnology company based in Copenhagen, Denmark, focused on developing peptide-based products for the treatment of degenerative eye disorders. The company’s portfolio includes RP001, a peptide drug designed for intravitreal injection, as well as additional peptide drugs RP002 and RP003. These products aim to provide neuroprotective effects in the eye, addressing critical needs in ophthalmic health care.